Hyperfine (HYPR) Cash & Equivalents (2020 - 2026)
Hyperfine's (HYPR) quarterly Cash & Equivalents came in at $40.8 million in Q1 2026, up 23.22% YoY from $33.1 million in Q1 2025, and up 16.23% on a QoQ basis from $35.1 million in Q4 2025.
Hyperfine (HYPR) Cash & Equivalents (2020 - 2026) Analysis & Trends
Hyperfine (HYPR) has 7 years of Cash & Equivalents data on file, last reported at $40.8 million in Q1 2026.
- Quarterly Cash & Equivalents rose 23.22% year-over-year to $40.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $40.8 million (up 23.22% YoY) and the FY2025 annual result came in at $35.1 million, down 6.8% from the prior year.
- Cash & Equivalents grew to $40.8 million in Q1 2026, from $35.1 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $161.6 million in Q1 2022 to a low of $21.6 million in Q3 2025.
- A 5-year average of $74.8 million and a median of $63.2 million in 2024 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2022 — Cash & Equivalents soared 102.34% — and 2025, when it plunged 52.88%.
- Tracing HYPR's Cash & Equivalents over 5 years: stood at $117.5 million in 2022, then tumbled by 36.0% to $75.2 million in 2023, then plunged by 49.93% to $37.6 million in 2024, then retreated by 6.8% to $35.1 million in 2025, then increased by 16.23% to $40.8 million in 2026.
- The last three Cash & Equivalents figures came in at $40.8 million (Q1 2026), $35.1 million (Q4 2025), and $21.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Hyperfine | 89.83 Mn | 45.06 Mn | 1.98 Mn | 43.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 43.46 Mn |
| Mar 31, 2026 | 40.78 Mn |
| Dec 31, 2025 | 35.09 Mn |
| Sep 30, 2025 | 21.56 Mn |
| Jun 30, 2025 | 25.42 Mn |
| Mar 31, 2025 | 33.09 Mn |
| Dec 31, 2024 | 37.65 Mn |
| Sep 30, 2024 | 45.77 Mn |
| Jun 30, 2024 | 53.81 Mn |
| Mar 31, 2024 | 63.20 Mn |
| Dec 31, 2023 | 75.18 Mn |
| Sep 30, 2023 | 85.42 Mn |
| Jun 30, 2023 | 93.95 Mn |
| Mar 31, 2023 | 104.03 Mn |
| Dec 31, 2022 | 117.47 Mn |
| Sep 30, 2022 | 132.48 Mn |
| Jun 30, 2022 | 145.10 Mn |
| Mar 31, 2022 | 161.58 Mn |
| Dec 31, 2021 | 188.50 Mn |
| Sep 30, 2021 | 65.48 Mn |